Innovations in Phase IV Clinical Trials for Change in Health Care
Read More:
Big Pharma,
Hippa,
Congress,
Public Health,
Fda,
Clinical Research,
Clinical Trials,
Pharmaceutical Companies,
Pharmaceutical Industry,
Health,
Hospitals,
Marketing,
Doctors,
Medicaid,
Medicare,
Food and Drug Administration,
Hmos,
Phase Iv,
Pharmaceuticals,
Hmo,
Politics News
For dying patients with no therapy that is working, compassionate use programs exist to provide drugs in phase II or III clinical trials when the patient was ineligible to participate in the trial.
Sunil Chacko | Posted 02.28.2009 | Politics